Video

ViaLase shares updates on new technology to treat glaucoma, company updates and upcoming trials

Author(s):

Kassi Filkins
Conferences|ASCRS

Tom Frinzi, executive chairman of ViaLase, a new company based in Orange County, gives an update on the company, sharing some exciting new things happening.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Related Content
Q&A: Understanding the influences on molecular confirmation after genetic testing for IRDs
August 13th 2025

Q&A: Understanding the influences on molecular confirmation after genetic testing for IRDs

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 13th 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Active lifestyle is tied to reduced visual field decline in primary open angle glaucoma
August 13th 2025

Active lifestyle is tied to reduced visual field decline in primary open angle glaucoma

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
August 13th 2025

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Q&A: Michael Lai, MD, PhD, on the impact of underfunding the Good Days program
August 13th 2025

Q&A: Michael Lai, MD, PhD, on the impact of underfunding the Good Days program

Q&A: PER-001 showed improved structure and visual function in patients with diabetic retinopathy
August 13th 2025

Q&A: PER-001 showed improved structure and visual function in patients with diabetic retinopathy

© 2025 MJH Life Sciences

All rights reserved.